Quick Takeaways
- Parag Saxena filed SCHEDULE 13D/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH).
- Disclosed ownership: 5.2%.
- Date of event: 18 Dec 2025.
Parag Saxena - 18 Dec 2025 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH)
- Filing Manager
- Parag Saxena
- Reporting Manager
- Parag Saxena
- Symbol
- RVPH
- Shares outstanding
- 120,538,577 shares
- Disclosed Ownership
- 6,268,006 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13D/A
- Filing time
- 22 Dec 2025, 16:30:05 UTC
- Date of event
- 18 Dec 2025
- Previous filing
- 24 Sep 2025
- Next filing
- 24 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Parag Saxena disclosed 5.2% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH) on 18 Dec 2025."
What Changed
- Previous schedule filing date: 24 Sep 2025.
- Current filing was accepted on 22 Dec 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| VEDANTA PARTNERS, LLC | 4.4% | 5,367,069 | 0 | 5,367,069 | /s/ Parag Saxena | Parag Saxena/CEO | 0001502216 |
| Parag Saxena | 5.2% | 6,268,006 | 900,937 | 5,376,069 | /s/ Parag Saxena | Parag Saxena/Individual | 0001015823 |